The Effect of Lixisenatide on the Effect of Pituitary Hormones

NCT05804513 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Healthy
Type 1 Diabetes

Interventions

DRUG: Placebo
DRUG: Lixisenatide 10 micrograms (50 micrograms/ml in 3 ml) Pen Injector

Sponsor

University of Tartu

Collaborators

[object Object]